| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/27/2007 | US7196169 Isolated post-translationally modified mammalian proteins for monitoring and diagnosing muscle damage |
| 03/27/2007 | US7196168 Metalloprotease-disintegrin ADAM23 (SVPH3-17) |
| 03/27/2007 | US7196164 Comprises nucleotide sequences coding signal sequence polypeptides for diagnosis, prevention and treatment of cell proliferative, cardiovascular and infectious disorders |
| 03/27/2007 | US7196163 Assays using amyloid precursor proteins with modified β-secretase cleavage sites to monitor β-secretase activity |
| 03/27/2007 | US7196105 Which suppresses I-kappa-B-alpha phosphorylation through inhibition kinase activity and downregulating NF-kappa-B; antiproliferative agents |
| 03/27/2007 | US7196069 High affinity RNA ligands of basic fibroblast growth factor |
| 03/27/2007 | US7196068 Downregulation of c-myc by promoting the ubiquitination of FBP, by administering an isolated p38/JTV-1protein or fragment or an isolated nucleic acid encoding said protein; |
| 03/27/2007 | US7195924 Method for immobilizing a biomolecule on a solid substrate at a high density by using the substrate having an activated carboxyl group on a surface thereof and microarray produced using the method |
| 03/27/2007 | US7195922 extracting from dust samples breakdown component of proteins or peptides, then reacting them with colorimetric amine detection reagents such as 2,4,6-trinitrobenzene sulfonic acid and quantitatively measuring the intensity of the resulting coloration |
| 03/27/2007 | US7195919 Hematology controls for reticulocytes and nucleated red blood cells |
| 03/27/2007 | US7195916 Method for expression of small antiviral RNA molecules within a cell |
| 03/27/2007 | US7195915 Vectors for animal cells and use thereof |
| 03/27/2007 | US7195913 Detecting preferential target in sample; provide microarray, incubate with sample, allow binding, detect signal from bound particles |
| 03/27/2007 | US7195910 Central nervous system disorders; antidiabetic agents |
| 03/27/2007 | US7195909 Measurement and use of molecular interactions |
| 03/27/2007 | US7195908 Supports treated with triamine for immobilizing biomolecules |
| 03/27/2007 | US7195903 Comprises metallloenzyme which is fibrinolytically active (fibrolase), for use in treating blood clots in situ |
| 03/27/2007 | US7195902 Expression vector comprising nucleotide sequences coding JNK activating phosphatase for use identifying modulator for treatment of inflammatory, arthritic, cardiovascular, respiratory cell proliferative and liver disorders |
| 03/27/2007 | US7195901 nucleotide sequence that code for polypeptides having transferase enzyme activity, used to transform plants and microorganisms, and and shows selective action for hydroxylated fatty acyl glycerides; castor oil biosynthesis with by-product inhibition |
| 03/27/2007 | US7195900 Comprises enzymatic polypeptide with amino acid oxidase activity for preparation of chemical intermediates for antibiotics and hypotensive agents |
| 03/27/2007 | US7195896 Complementary adenoviral vector systems and cell lines |
| 03/27/2007 | US7195895 Amplifying nucleotide sequences and using produts for in vitro translation; structural genomics |
| 03/27/2007 | US7195891 Methods and compositions of enzymatic cycling based assays for myeloperoxidase |
| 03/27/2007 | US7195890 Methods and compositions for modulating proteins modified in preconditioning against ischemia/hypoxia |
| 03/27/2007 | US7195889 Mixing salt of tris(m-sulfonatophenyl)phosphine with oxidoreductases and reducing with hydrogen |
| 03/27/2007 | US7195888 Determining if a compound is an anti-arrhythmia or myocardial salvage drug by detecting a change in enzyme expression level; quantifying release of fatty acids into the effluent of myocardium; animal models |
| 03/27/2007 | US7195887 Nucleic acid fragments encoding 1-deoxy-D-xylulose 5-phosphate synthase in plants and seeds; isopentenyl diphosphate biosynthetic enzymes; enzyme inhibitors |
| 03/27/2007 | US7195886 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents |
| 03/27/2007 | US7195885 Hepatitis C virus assays |
| 03/27/2007 | US7195884 Using peptide substrates to measure enzyme activity; enzyme inhibitors; modulators |
| 03/27/2007 | US7195880 DNA-protein fusions and uses thereof |
| 03/27/2007 | US7195878 Device and method for fecal testing |
| 03/27/2007 | US7195877 Primer set for identifying allelic variation liver metabolic enzyme; screening for antiarrhythmics, beta -receptor blockers, neuroleptics, serotonin reuptake inhibitors and antidepressants |
| 03/27/2007 | US7195876 Comprises chimeric fusion protein composed of tyrosine kinase domain for diagnosis, prevention and treatment of tumors |
| 03/27/2007 | US7195875 Bioassay for sorting, detecting and identifying analytes; genomics |
| 03/27/2007 | US7195874 Using conjugate agents comprise of photoreactive moiety to identify preferential micro and/or macromolecules in heterologous mixtures |
| 03/27/2007 | US7195873 Drug response marker in beta-1 adrenergic receptor gene |
| 03/27/2007 | US7195872 Comprises substrate containing coatings such as silica and titania and dopants such as lithium oxide and sodium oxide for use on surface of bioreactor; analysis/sequencing biopolymers; microfluidics |
| 03/27/2007 | US7195871 Cleaving with nucleases; forensic analysis and paternity testing |
| 03/27/2007 | US7195870 Diagnosis of diseases associated with gene regulation |
| 03/27/2007 | US7195869 Comprises fusion proteins with green fluorescent protein to construct gene expression library; transcription factors; for treating tumor necrosis factor-related diseases |
| 03/27/2007 | US7195868 Compositions and methods for the identification, assessment, prevention, and therapy of human cancers |
| 03/27/2007 | US7195867 Method for detection of multiple test materials in a sample |
| 03/27/2007 | US7195866 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 03/27/2007 | US7195765 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
| 03/27/2007 | US7195751 For the determination of an analyte or analytes such as proteins, peptides, nucleic acids, carbohydrates, lipids, steroids and small molecules by mass analysis |
| 03/27/2007 | US7195738 Sensor and detecting method |
| 03/27/2007 | US7195670 High throughput screening of crystallization of materials |
| 03/27/2007 | CA2375787C Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abc1 |
| 03/27/2007 | CA2352064C Magnetic separation apparatus and methods |
| 03/27/2007 | CA2311431C Sample detection to initiate timing of an electrochemical assay |
| 03/27/2007 | CA2219038C Immortalized human corneal epithelial cell line |
| 03/27/2007 | CA2201571C Reagent test strip for blood glucose determination |
| 03/27/2007 | CA2200582C Dna encoding human papillomavirus type 6a |
| 03/27/2007 | CA2191583C Methods and compositions for modulating morphogenic protein expression |
| 03/27/2007 | CA1341523C Cloned dna sequences, hybridizable with genomic rna of lymphadenopathy-associated virus (lav) |
| 03/23/2007 | CA2558624A1 Fabp4 as marker for a toxic effect |
| 03/22/2007 | WO2007033283A2 Disposable electrode system for detection of selected nucleic acid sequences |
| 03/22/2007 | WO2007033210A2 Alien sequences |
| 03/22/2007 | WO2007033187A2 Recurrent gene fusions in prostate cancer |
| 03/22/2007 | WO2007033118A2 Mek interacting protein 1 and breast cancer |
| 03/22/2007 | WO2007033079A2 Method of manufacturing a diagnostic test strip |
| 03/22/2007 | WO2007033007A1 Electrochemical sensor and method for determining the concentration of an analyte in a sample |
| 03/22/2007 | WO2007032984A2 Cyp1b1 genotype |
| 03/22/2007 | WO2007032953A1 Chemical and biological detection arrays |
| 03/22/2007 | WO2007032876A2 Biomarkers associated with age-related macular degeneration |
| 03/22/2007 | WO2007032859A2 Method and system for the generation of large double stranded dna fragments |
| 03/22/2007 | WO2007032817A2 Pure mirna sample preparation method |
| 03/22/2007 | WO2007032793A1 Multiplex array useful for assaying protein-protein interaction |
| 03/22/2007 | WO2007032748A1 Method for detecting dna methylation |
| 03/22/2007 | WO2007032743A2 In vitro assay for identification of allergenic proteins |
| 03/22/2007 | WO2007032691A1 A microbiological growth device and a method of use |
| 03/22/2007 | WO2007032631A1 Markers for diagnosis of cancer and its use |
| 03/22/2007 | WO2007032587A1 Adhesive bead for immobilization of biomolecules and method for fabricating a biochip using the same |
| 03/22/2007 | WO2007032568A1 Method for improving organisms using flux scanning based on enforced objective flux |
| 03/22/2007 | WO2007032555A1 Method of controlling decomposition of protein by tetracycline antibiotic |
| 03/22/2007 | WO2007032544A1 Method of detecting reactive metabolite |
| 03/22/2007 | WO2007032536A1 Histamine h3 agonist for use as therapeutic agent for lipid/glucose metabolic disorder |
| 03/22/2007 | WO2007032521A1 Gene encoding proteinase a and use thereof |
| 03/22/2007 | WO2007032496A1 Method for determination of risk of type 2 diabetes |
| 03/22/2007 | WO2007032482A1 Genetic polymorphism useful for prediction of response to anti-depressant agent |
| 03/22/2007 | WO2007032428A1 NOVEL LOOP SEQUENCE EFFECTIVE FOR EXPRESSION OF shRNA |
| 03/22/2007 | WO2007032426A1 Diagnostic marker for migraine and use thereof |
| 03/22/2007 | WO2007032373A1 Analysis method on risk of tumor formation |
| 03/22/2007 | WO2007032359A1 Method for detecting target molecule using aptamer/probe complex |
| 03/22/2007 | WO2007032264A1 Method for determination of effective dose of methotrexate |
| 03/22/2007 | WO2007032160A1 Marker gene for examining hypertension |
| 03/22/2007 | WO2007031792A1 Dog periodontitis |
| 03/22/2007 | WO2007031789A1 Gins gene expression as marker for actively cycling cells and cell cycle phase |
| 03/22/2007 | WO2007031717A1 Mass labels |
| 03/22/2007 | WO2007031590A1 Method for the in vitro detection of a predisposition to the development of alterations in ovarian function |
| 03/22/2007 | WO2007031322A1 Compositions comprising immunostimulatory rna oligonucleotides and methods for producing said rna oligonucleotides |
| 03/22/2007 | WO2007031319A1 Compositions comprising immunostimulatory rna oligonucleotides and methods for producing said rna oligonucleotides |
| 03/22/2007 | WO2007031273A2 Artificial immune-reconstituted epidermis equivalents |
| 03/22/2007 | WO2007031222A2 Identification of tumor-associated antigens for diagnosis and therapy |
| 03/22/2007 | WO2007031150A1 Detection of presence and antibiotic susceptibility of enterococci |
| 03/22/2007 | WO2007030949A2 Methods of diagnosing ovarian cancer and kits therefor |
| 03/22/2007 | WO2007030937A2 Screening proteinase modulators using a chimeric protein and ski-i proprotein convertase substrates and inhibitors |
| 03/22/2007 | WO2007030919A1 Molecular method for diagnosis of prostate cancer |
| 03/22/2007 | WO2007030882A1 Assay for a health state |